These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM). Oster MW; Gray R; Panasci L; Perry MC Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary disease as a complication of chlorozotocin chemotherapy. Ahlgren JD; Smith FP; Kerwin DM; Sikic BI; Weiner JH; Schein PS Cancer Treat Rep; 1981; 65(3-4):223-9. PubMed ID: 6453644 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma. Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223 [TBL] [Abstract][Full Text] [Related]
8. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159 [TBL] [Abstract][Full Text] [Related]
9. Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma-preliminary results. Bukowski RM; Gahbauer R; Rodriquez-Antunez A; Hermann R Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1231-3. PubMed ID: 6214533 [TBL] [Abstract][Full Text] [Related]
10. Cholestatic jaundice associated with chlorozotocin. Belt RJ; McGregor D; Haas CD; Bhatia PS Cancer Treat Rep; 1980; 64(12):1235-9. PubMed ID: 6451288 [TBL] [Abstract][Full Text] [Related]
11. Feasibility study of combining metronidazole with chemotherapy. Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002 [TBL] [Abstract][Full Text] [Related]
12. The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer. Gisselbrecht C; Smith FP; MacDonald JS; Korsmeyer SJ; Boiron M; Woolley PV; Schein PS Cancer; 1983 May; 51(10):1792-4. PubMed ID: 6219735 [TBL] [Abstract][Full Text] [Related]
13. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group. Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131 [TBL] [Abstract][Full Text] [Related]
15. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742 [TBL] [Abstract][Full Text] [Related]
16. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma. Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042 [TBL] [Abstract][Full Text] [Related]
17. Interstitial pneumonitis associated with mitomycin C and DTIC: a case report. Yoon JM; Rao U; Vassilopoulos PP; Ledesma E; Mittelman A Med Pediatr Oncol; 1981; 9(1):61-7. PubMed ID: 7464693 [TBL] [Abstract][Full Text] [Related]